BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25924702)

  • 1. Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis.
    Xu S; Li X; Zhang J; Chen J
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1859-70. PubMed ID: 25924702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis.
    Xu S; Li X; Zhang J; Chen J
    PLoS One; 2015; 10(8):e0135981. PubMed ID: 26309131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis.
    Yi-Ning Y; Xiao-rui W; Chu-xian Z; Chun W; You-wen Q
    Ann Hematol; 2015 Jun; 94(6):929-38. PubMed ID: 25572170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
    Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
    Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between Isocitrate Dehydrogenase Gene Aberrations and Prognosis of Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
    Xu Q; Li Y; Lv N; Jing Y; Xu Y; Li Y; Li W; Yao Z; Chen X; Huang S; Wang L; Li Y; Yu L
    Clin Cancer Res; 2017 Aug; 23(15):4511-4522. PubMed ID: 28246275
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.
    Qin Y; Shen K; Liu T; Ma H
    BMC Cancer; 2023 Jun; 23(1):527. PubMed ID: 37291515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
    Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
    Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
    Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
    Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
    Wang R; Gao X; Yu L
    BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
    Jiang A; Jiang H; Brandwein J; Kamel-Reid S; Chang H
    Leuk Res; 2011 Apr; 35(4):492-8. PubMed ID: 20684989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
    Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
    Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis.
    Li HY; Deng DH; Huang Y; Ye FH; Huang LL; Xiao Q; Zhang B; Ye BB; Lai YR; Mo ZN; Liu ZF
    Eur J Haematol; 2015 May; 94(5):439-48. PubMed ID: 25227715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56 and RUNX1 isoforms in AML prognosis and their therapeutic potential.
    Zaidi SZ; Motabi IH; Al-Shanqeeti A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):129-30. PubMed ID: 26706848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of CD56 in acute leukemia and its clinical significance].
    Zhang Y; Tang YM; Yang SL; Shen HQ; Qian BQ; Song H; Shi SW; Xu WQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):187-90. PubMed ID: 12513782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
    Chen W; Xie H; Wang H; Chen L; Sun Y; Chen Z; Li Q
    PLoS One; 2016; 11(1):e0146614. PubMed ID: 26771376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLT3-internal tandem duplication in a pediatric patient with t(8;21) acute myeloid leukemia.
    Kawamura M; Kaku H; Ito T; Funata N; Taki T; Shimada A; Hayashi Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):292-6. PubMed ID: 21156247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study.
    Wan H; Zhu J; Chen F; Xiao F; Huang H; Han X; Zhong L; Zhong H; Xu L; Ni B; Zhong J
    J Exp Clin Cancer Res; 2014 Nov; 33(1):90. PubMed ID: 25398670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis.
    Juncà J; Garcia-Caro M; Granada I; Rodríguez-Hernández I; Torrent A; Morgades M; Ribera JM; Millá F; Feliu E
    Ann Hematol; 2014 Sep; 93(9):1483-9. PubMed ID: 24782118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.